BOT.AX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 08:10):

Stats
Dagens volum	3.27M
Gjennomsnittsvolum	2.57M
Markedsverdi	346.53M
EPS	$0 ( 2024-02-25 )
Neste inntjeningsdato	( $0 ) 2024-07-28
Last Dividend	$95.85 ( 1996-10-03 )
Next Dividend	$0 ( N/A )
P/E	-22.00
ATR14	$0.00200 (0.93%)

Volum Korrelasjon

Lang: 0.12 (neutral)

Kort: 0.22 (neutral)

Signal:(40.465) Neutral

Botanix Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Botanix Pharmaceuticals Korrelasjon - Valuta/Råvare

0.00
( neutral )

-0.44
( neutral )

Botanix Pharmaceuticals Økonomi

Annual	2023
Omsetning:	$914 973
Bruttogevinst:	$-3.05M (-332.90 %)
EPS:	$-0.00790

FY	2023
Omsetning:	$914 973
Bruttogevinst:	$-3.05M (-332.90 %)
EPS:	$-0.00790

FY	2022
Omsetning:	$2.75M
Bruttogevinst:	$2.61M (94.79 %)
EPS:	$-0.0135

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.00438

Financial Reports:

No articles found.

Botanix Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Botanix Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$81.28	1994-02-18
Last Dividend	$95.85	1996-10-03
Next Dividend	$0	N/A
Payout Date	1996-10-25
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$510.23	--
Avg. Dividend % Per Year	0.00%	--
Score	1.06	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-11-04)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.06

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SIG.AX	Ex Dividend Knight	2023-09-25	Annually	0.00%
CIA.AX	Ex Dividend Knight	2023-06-13	Semi-Annually	0.00%
MMS.AX	Ex Dividend Junior	2023-09-07	Annually	0.00%
URF.AX	No Dividend Player	2023-06-29	Annually	0.00%
DJW.AX	Ex Dividend Knight	2023-08-10	Semi-Annually	0.00%
OMH.AX	Ex Dividend Junior	2023-05-04	Sporadic	0.00%
AFG.AX	Ex Dividend Junior	2023-09-04	Semi-Annually	0.00%
GDG.AX	Ex Dividend Junior	2023-09-08	Semi-Annually	0.00%
QBE.AX	Ex Dividend Knight	2023-08-17	Annually	0.00%
BBN.AX	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-11.08	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.210	1.200	-7.01	-8.41	[0 - 0.3]
returnOnEquityTTM	-0.293	1.500	-4.37	-6.56	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	9.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.09	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	7.99	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-858.83	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.00702	2.00	-0.00234	-0.00468	[0 - 30]
freeCashFlowPerShareTTM	-0.0186	2.00	-0.00932	-0.0186	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	-5.76	1.000	-10.00	-10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-11.10	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0190	0.800	-3.21	-2.57	[0.5 - 2]
Total Score				-3.67

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-31.58	1.000	-3.29	0	[1 - 100]
returnOnEquityTTM	-0.293	2.50	-2.81	-6.56	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0186	2.00	-0.00621	-0.0186	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00702	2.00	-0.00234	-0.00468	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.106	1.500	-2.62	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-11.17	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.43

Botanix Pharmaceuticals

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.